Supriya Lifescience Limited (NSE:SUPRIYA)

India flag India · Delayed Price · Currency is INR
733.45
-0.90 (-0.12%)
Mar 28, 2025, 3:30 PM IST
116.04%
Market Cap 59.09B
Revenue (ttm) 6.71B
Net Income (ttm) 1.75B
Shares Out 80.48M
EPS (ttm) 21.66
PE Ratio 33.89
Forward PE n/a
Dividend 0.80 (0.11%)
Ex-Dividend Date Sep 20, 2024
Volume 180,922
Average Volume 352,198
Open 739.90
Previous Close 734.35
Day's Range 725.55 - 754.75
52-Week Range 330.00 - 835.20
Beta 0.19
RSI 60.12
Earnings Date May 23, 2025

About Supriya Lifescience

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, anti-malarial products, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, it also offers GelHeal, a wound care solution; and Quickblue, an oral cancer det... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1987
Employees 448
Stock Exchange National Stock Exchange of India
Ticker Symbol SUPRIYA
Full Company Profile

Financial Performance

In 2023, Supriya Lifescience's revenue was 5.70 billion, an increase of 23.74% compared to the previous year's 4.61 billion. Earnings were 1.19 billion, an increase of 32.56%.

Financial Statements

News

There is no news available yet.